Curated, not exhaustive. Grouped by the work they evidence.
Coverage of the Sapio and Zifo strategic partnership, with CEO Raj Prakash describing how the integration of LDAS with the Sapio Platform unlocked AI adoption in biotech and pharma labs.
Read on Cambridge Network →Tier-one services partner EPAM joins the Sapio partner programme, expanding global delivery capability across life sciences and healthcare informatics.
Read on Cambridge Network →Tier-one life sciences trade coverage of the Sapio partner programme launch, designed to accelerate research and diagnostics through deployment, consulting and technology partners.
Read in The Scientist →Why isolated AI tools underperform AI ecosystems, and what this shift means for lab science companies architecting their next generation of platform partnerships.
Read on IPT Online →The trust problem with generative AI in regulated lab environments, and the architectural choices that separate credible AI from confident-sounding noise.
Read on Bioscience Today →The Cambridge Crystallographic Data Centre announces an AI technology partnership with Sapio Sciences, evidencing the ecosystem thesis with a credible scientific institution.
Read on CCDC →Long-form interview on the role of modern lab informatics in research and clinical efficiency, and where boards should be paying attention to the data layer.
Read in BioPharma Boardroom →How disciplined data management changes the economics of diagnosis and drug development, with implications for SaaS platforms supporting biopharma R&D.
Read in Pharmaceutical Technology →Pre-exit coverage of Apertio, the network platform business subsequently acquired by Nokia. One of four prior exits in Andrew's operating history.
Read on Light Reading →Investor portfolio reference for Lumeon, the deterministic clinical-pathway orchestration platform where Andrew served in the executive team during its venture-backed scale phase.
Read on Amadeus Capital →A maturity framework for lab AI, from passive data systems through assistive tools to AI as a co-scientist, with implications for platform architecture and partner strategy.
Read on Technology Networks →How the electronic lab notebook category is being redefined by AI, and what changes for platform vendors, services partners and the labs themselves.
Read in Lab Manager →Commentary during Andrew's Clearswift tenure on the risks enterprises were facing as social media moved into corporate workflows.
Read in WSJ →FT coverage of how organisations were responding to social-media risk and data-protection demands, with input from Andrew at Clearswift.
Read in the FT →Comment on the friction of early smartphone adoption — context from Andrew's mobile telecoms operating period before Apertio.
Read on BBC News →Andrew byline on the data-management discipline that lets life sciences platforms convert volume into actual decisions, and where the platform layer matters.
Read on TechRadar Pro →Tier-one bioinformatics trade coverage of Astrix joining the Sapio partner programme during Andrew's CGO tenure, expanding services capability across the platform.
Read in Bio-IT World →A curated selection across six bodies of work. Older press from prior exits and earlier roles is not listed but available on request. For interview, comment or quote requests, use the contact form below.
For interview, comment or quote requests, or to discuss a board, advisory or fractional engagement, email directly. Thirty minutes is usually enough to test fit.
Book a 30-minute intro call